1. Apostolopoulos A, Symeonidis A, Zoumbos N (1990) Prognostic significance of immune function parameters in patients with chronic lymphocytic leukaemia. Eur J Haematol 44:39
2. Barlozzari T, Leonhardt J, Wiltrout RH, Herberman RB, Reynolds CW (1985) Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. J Immunol 134:2783
3. Boldt DH, Von Hoff DD, Kuhn JG, Hersh M (1984) Effects on human peripheral lymphocytes of in vivo administration of 9-β-D-arabinofuranosyl-2-fluoroadenine-5′-monophosphate (NSC 31887), a new purine antimetabolite. Cancer Res 44:4661
4. Catapano CV, Chandler K, Fernandes DJ (1991) Inhibition of primer RNA formation in CCRF-CEM leukemia cells by fludarabine triphosphate. Cancer Res 51:18295
5. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Bolt DH, Kempin SJ, Foon KA (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-Sponsored Working Group. Am J Hematol 29:152